Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACVR1 | Q04771 | 20/20 | 0.61 |
| ▸ | BMPR1B | O00238 | 4/20 | 0.49 |
| ▸ | BMPR1A | P36894 | 4/20 | 0.49 |
| ▸ | ACVR1B | P36896 | 4/20 | 0.49 |
| ▸ | ACVRL1 | P37023 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23988689 | 0.91 | ACVR1 (0.60) | ACVR1BMPR1BBMPR1AACVR1BACVRL1 | |
| SCHEMBL23988862 | 0.85 | ACVR1 (0.48) | ACVR1BMPR1BBMPR1AACVR1BACVRL1 | |
| SCHEMBL23988675 | 0.84 | ACVR1 (0.67) | ACVR1BMPR1BBMPR1AACVR1BACVRL1 | |
| SCHEMBL23988795 | 0.82 | ACVR1 (0.76) | ACVR1BMPR1BBMPR1AACVR1B | |
| SCHEMBL23988792 | 0.80 | ACVR1 (0.61) | ACVR1BMPR1BBMPR1AACVR1BACVRL1 | |
| SCHEMBL23988751 | 0.78 | ACVR1 (0.62) | ACVR1BMPR1BBMPR1AACVR1BACVRL1 | |
| SCHEMBL22077836 | 0.77 | ACVR1 (1.00) | ACVR1BMPR1BBMPR1AACVR1B | |
| SCHEMBL22074396 | 0.76 | ACVR1 (1.00) | ACVR1BMPR1BBMPR1AACVR1B | |
| SCHEMBL23988822 | 0.74 | ACVR1 (0.72) | ACVR1BMPR1BBMPR1AACVR1BACVRL1 | |
| SCHEMBL23988859 | 0.74 | ACVR1 (0.62) | ACVR1BMPR1BBMPR1AACVR1BACVRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021222875-A1 | METHODS OF USING ALK2 INHIBITORS | KEROS THERAPEUTICS, INC. (US) | 2021-11-04 | — | — | WO | disclosed |